Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03253198 · ClinicalTrials.gov registry record · NA

Prospective RCT Comparing Perioperative Pain

A NA study of Arthroplasty Shoulder, sponsored by Rothman Institute Orthopaedics.

Completed
Registry status
NA
Development phase
156
Enrollment target
1
Study location

NCT03253198 is a NA study of Arthroplasty Shoulder that has completed, run by Rothman Institute Orthopaedics. The registered enrollment target is 156 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03253198, a NA study of Arthroplasty Shoulder, has completed, sponsored by Rothman Institute Orthopaedics.

COMPLETED
Registry status
NA
Development phase
156 participants
Enrollment target
1
Study location

Study Summary

This study is a non-blinded randomized controlled trial comparing the use of a preoperative "mini" block plus postoperative local infiltration of Exparel (liposomal form of bupivacaine) versus a partial single shot nerve block in subjects undergoing primary reverse or total shoulder arthroplasty to see which is more effective in controlling surgery related pain. To do so, we will utilize the Visual Analog Scale (VAS) to measure pain intensity. Opioid consumption will be recorded on a Pain Monitoring Sheet.

Conditions Studied

Interventions

  • DRUG Saline
  • DRUG Bupivacaine liposome

Study Locations (1)

Pennsylvania

  • Rothman Institute - Philadelphia

Trial Details

FieldValue
Enrollment Target 156 participants
Start Date 2016-08
Est. Completion 2017-07
Phase NA

Sponsor

Rothman Institute Orthopaedics

23 total trials

What the Registry Record Tells You About NCT03253198

The ClinicalTrials.gov registry entry for NCT03253198 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rothman Institute Orthopaedics, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Arthroplasty Shoulder appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.

NCT03253198 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03253198 about?

NCT03253198 is a clinical study titled "Prospective RCT Comparing Perioperative Pain". This study is a non-blinded randomized controlled trial comparing the use of a preoperative "mini" block plus postoperative local infiltration of Exparel (liposomal form of bupivacaine) versus a partial single shot nerve block in subjects undergoing primary reverse or total shoulder arthroplasty to ...

What is the current status of trial NCT03253198?

This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2016-08. Estimated completion is 2017-07.

What conditions does trial NCT03253198 study?

This clinical trial studies the following conditions: Arthroplasty Shoulder.

What interventions are being tested in trial NCT03253198?

The interventions under investigation include: Saline (DRUG), Bupivacaine liposome (DRUG).

Who is sponsoring clinical trial NCT03253198?

This trial is sponsored by Rothman Institute Orthopaedics, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03253198 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthroplasty Shoulder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.